The iShares
MSCI Israel Capped Investable Market Index (EIS),
an exchange-traded fund (ETF), started trading on March 26, 2008.
As of June 30, 2008 EIS held 72 Israeli-based stocks. The top sectors
include health care, materials, financials, information technology,
industrials and telecommunications.
Teva Pharmaceuticals,
one of the world's largest generic pharmaceutical companies, makes
up 22.50 percent of EIS by percent net assets followed by Israel
Chemicals Limited (14.58%), Bank
Leumi Le-Israel (4.77%). Makhteshim
Agan Industries, (4.34%), Check
Point Software Technologies (4.25%) and Bank
Hapoalim. (4.08%).
EIS on July 25 closed at $50.73, down from its all-time high of
$58.61 set on May 30, 2008 (price
chart).
EIS has an expense ratio of 0.68 percent.
Related Articles:
Claymore BNY/Mellon Frontier
Markets ETF Offers Exposure to 17 Frontier Markets
Market Vectors-Africa Index
ETF Features 11 African Countries
Market Vectors Gulf States
Index ETF Includes Gulf Cooperation Council Stocks
NETS TA-25 Index Tracks Large
Israeli Stocks
Own MENA (Middle East, North Africa)
Stocks With Eight ETFs
PowerShares MENA Frontier
Countries Portfolio Includes Middle East Stocks
SPDR S&P
Emerging Middle East & Africa Features South African and Israeli
Stocks
WisdomTree
Middle East Dividend Fund Begins Trading
Updated August 15, 2008.
|
|
